Closing Bell: Hls Therapeutics Inc up on Friday (HLS)

Today during trading, Hls Therapeutics Inc shares closed at $3.15 after opening the day at $3.02. Intraday prices ranged from $3.02 to $3.15.

Shares boosted 0.32% from the previous day's close of $3.14.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

Trading volume was 345 on 4 total trades, with an average volume of 970 over the last 5 days.

The TSX overall saw 741 price advancers against 4,512 declines and 69 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.00 (August 03,2023) and low as $3.02 (August 02,2024). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have reduced -47.50 percent, while they have plummeted -20.25% since the start of 2024.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $99.90 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 5.00 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..